Anti-Obesity Drugs Mounjaro and Wegovy Gain Traction and Reimbursement in France

The anti-obesity medications Mounjaro and Wegovy are becoming more prevalent in France, now covered by social security for individuals with obesity or diabetes.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

le-figaroFrench14d ago

Mounjaro, Wegovy… Le phénomène des médicaments antiobésité s’installe en France

Ces deux traitements sont désormais remboursés par la Sécurité sociale pour les personnes obèses ou diabétiques.

Read full article →

PERSPECTA

PERSPECTA

Anti-Obesity Drugs Mounjaro and Wegovy Gain Traction and Reimbursement in France

Sources

Mounjaro, Wegovy… Le phénomène des médicaments antiobésité s’installe en France

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

SMEDAN secures $12m Korean funding and launches N500m MSME fund

Ex-Ogun HoS urges diaspora investment

ECB Forum in Sintra Anticipates New Fed Chief

PERSPECTA